Breast Imaging BI-RADS Category & Management — free guideline decision tool
Look up the malignancy likelihood and standardised management for any ACR BI-RADS breast-imaging category (0–6). Instant, browser-side.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| BI-RADS category | 0 — Incomplete |
|---|
→ManagementAdditional imaging / prior comparison
- Category：BI-RADS 0: Incomplete assessment
- Management：Additional imaging (spot/magnification views, ultrasound) or comparison with priors, then assign a final category
- Note：BI-RADS management falls into four groups: additional imaging, routine screening, short-interval follow-up, biopsy; only 0/1/2 are used for screening, 3/4/5/6 after a diagnostic work-up
| BI-RADS category | 6 — Known biopsy-proven malignancy |
|---|
→ManagementDefinitive treatment
- Category：BI-RADS 6: Biopsy-proven malignancy
- Management：Definitive treatment (surgery/chemotherapy, etc.); imaging is used to assess treatment response
- Note：BI-RADS management falls into four groups: additional imaging, routine screening, short-interval follow-up, biopsy; only 0/1/2 are used for screening, 3/4/5/6 after a diagnostic work-up
Common questions
What is Breast Imaging BI-RADS Category & Management?
Look up the malignancy likelihood and standardised management for any ACR BI-RADS breast-imaging category (0–6). Instant, browser-side.
How is Breast Imaging BI-RADS Category & Management calculated? What is the core formula?
0 incomplete → additional imaging; 1/2 → routine screening; 3 (< 2%) → short-interval follow-up; 4A/4B/4C (2–95%) and 5 (≥ 95%) → biopsy; 6 → definitive treatment.
When is Breast Imaging BI-RADS Category & Management used?
Translate an assigned BI-RADS category into the correct management pathway.
What are the key clinical points for Breast Imaging BI-RADS Category & Management?
Only categories 0/1/2 are used for screening; 3/4/5/6 follow a diagnostic work-up. Category 3 (probably benign) means malignancy < 2% and short-interval follow-up. A benign biopsy discordant with imaging in category 4C/5 needs further action. Category 4 is sub-divided 4A/4B/4C by the physician's malignancy estimate.
What are the limits and cautions when using Breast Imaging BI-RADS Category & Management?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
How is Breast Imaging BI-RADS Category & Management calculated in practice? Can you show a worked example?
Inputs: BI-RADS category 0 — Incomplete → Result: Management Additional imaging / prior comparison（Category: BI-RADS 0: Incomplete assessment, Management: Additional imaging (spot/magnification views, ultrasound) or comparison with priors, then assign a final category, Note: BI-RADS management falls into four groups: additional imaging, routine screening, short-interval follow-up, biopsy; only 0/1/2 are used for screening, 3/4/5/6 after a diagnostic work-up） Inputs: BI-RADS category 6 — Known biopsy-proven malignancy → Result: Management Definitive treatment（Category: BI-RADS 6: Biopsy-proven malignancy, Management: Definitive treatment (surgery/chemotherapy, etc.); imaging is used to assess treatment response, Note: BI-RADS management falls into four groups: additional imaging, routine screening, short-interval follow-up, biopsy; only 0/1/2 are used for screening, 3/4/5/6 after a diagnostic work-up）
Run Breast Imaging BI-RADS Category & Management now
Look up the malignancy likelihood and standardised management for any ACR BI-RADS breast-imaging category (0–6). Instant, browser-side.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.